These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29212715)

  • 21. N-myc downstream regulated family member 1 (NDRG1) is enriched in myelinating oligodendrocytes and impacts myelin degradation in response to demyelination.
    Marechal D; Dansu DK; Castro K; Patzig J; Magri L; Inbar B; Gacias M; Moyon S; Casaccia P
    Glia; 2022 Feb; 70(2):321-336. PubMed ID: 34687571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered human oligodendrocyte heterogeneity in multiple sclerosis.
    Jäkel S; Agirre E; Mendanha Falcão A; van Bruggen D; Lee KW; Knuesel I; Malhotra D; Ffrench-Constant C; Williams A; Castelo-Branco G
    Nature; 2019 Feb; 566(7745):543-547. PubMed ID: 30747918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
    Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
    Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
    Rone MB; Cui QL; Fang J; Wang LC; Zhang J; Khan D; Bedard M; Almazan G; Ludwin SK; Jones R; Kennedy TE; Antel JP
    J Neurosci; 2016 Apr; 36(17):4698-707. PubMed ID: 27122029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies.
    McCaughey-Chapman A; Connor B
    J Neurosci Res; 2023 Jun; 101(6):1000-1028. PubMed ID: 36749877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation.
    Roggeri A; Schepers M; Tiane A; Rombaut B; van Veggel L; Hellings N; Prickaerts J; Pittaluga A; Vanmierlo T
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TMEM10 Promotes Oligodendrocyte Differentiation and is Expressed by Oligodendrocytes in Human Remyelinating Multiple Sclerosis Plaques.
    de Faria O; Dhaunchak AS; Kamen Y; Roth AD; Kuhlmann T; Colman DR; Kennedy TE
    Sci Rep; 2019 Mar; 9(1):3606. PubMed ID: 30837646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Tau protein as a novel marker for maturation and pathological changes of oligodendrocytes.
    Torii T; Miyamoto Y; Nakata R; Higashi Y; Shinmyo Y; Kawasaki H; Miyasaka T; Misonou H
    Glia; 2023 Apr; 71(4):1002-1017. PubMed ID: 36565228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.
    Lucchinetti C; Brück W; Parisi J; Scheithauer B; Rodriguez M; Lassmann H
    Brain; 1999 Dec; 122 ( Pt 12)():2279-95. PubMed ID: 10581222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of oligodendroglia pathology in multiple sclerosis.
    Ozawa K; Suchanek G; Breitschopf H; Brück W; Budka H; Jellinger K; Lassmann H
    Brain; 1994 Dec; 117 ( Pt 6)():1311-22. PubMed ID: 7820568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?
    Cui QL; Khan D; Rone M; T S Rao V; Johnson RM; Lin YH; Bilodeau PA; Hall JA; Rodriguez M; Kennedy TE; Ludwin SK; Antel JP
    Ann Neurol; 2017 Jun; 81(6):811-824. PubMed ID: 28470695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis.
    Harrington EP; Catenacci RB; Smith MD; Heo D; Miller CE; Meyers KR; Glatzer J; Bergles DE; Calabresi PA
    Elife; 2023 Apr; 12():. PubMed ID: 37057892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
    Linden JR; Ma Y; Zhao B; Harris JM; Rumah KR; Schaeren-Wiemers N; Vartanian T
    mBio; 2015 Jun; 6(3):e02513. PubMed ID: 26081637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
    Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
    Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.